Proteinuria typing: how, why and for whom?

被引:4
|
作者
Pallet, Nicolas [1 ]
Bastard, Jean-Philippe [2 ]
Claeyssens, Sophie [3 ]
Fellahi, Soraya [2 ]
Delanaye, Pierre [4 ]
Pieroni, Laurence [5 ]
Causse, Elizabeth [6 ]
机构
[1] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France
[2] Hop Tenon, AP HP, UF Biomarqueurs Inflammatoires & Metabol, Serv Biochim & Hormonol, Paris, France
[3] CHU Rouen, Hop Charles Nicolle, Lab Biochim Gen, Rouen, France
[4] CHU Sart Tilman, Serv Nephrol, Dialyse, Transplantat, Liege, Belgium
[5] CHU Montpellier, Hop Lapeyronie, Dept Biochim Hormonol, Montpellier, France
[6] CHU Purpan, Lab Biochim, Inst Federatif Biol, Toulouse, France
关键词
proteinuria; urinary electrophoresis; urinary protein profiling; kidney disease; monoclonal gammopathy; ACUTE KIDNEY INJURY; PROXIMAL TUBULE; URINARY PROTEINS; MANAGEMENT; DIAGNOSIS; ELECTROPHORESIS; RECOMMENDATIONS; SERUM; IGG;
D O I
10.1684/abc.2018.1401
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The typing of proteinuria is one of the complementary examinations carried out during the exploration of proteinuria. It aims to separate and identify the different proteins, or fractions of proteins, that make up proteinuria. The nature and relative importance of the proteins present reflect the location of the renal involvement and help to determine the etiology. The typing of a proteinuria also allows the detection of a monoclonal component in urine and its quantification. Finally, it allows highlighting the existence of a proteinuria of overload that can occur in the absence of kidney damage. Many methods allow the typing of proteinuria, and these have benefited in recent years from technological advances. The purpose of this review is to summarize typing methods currently used, their benefits and limitations, and the help that these diagnostic tools can provide to the management of patients.
引用
收藏
页码:13 / 25
页数:13
相关论文
共 50 条
  • [21] The birth of cultural autonomy in Estonia: How, why, and for whom?
    Alenius, Kari
    [J]. JOURNAL OF BALTIC STUDIES, 2007, 38 (04) : 445 - 462
  • [22] Viewing Internet Pornography: For Whom is it Problematic, How, and Why?
    Twohig, Michael P.
    Crosby, Jesse M.
    Cox, Jared M.
    [J]. SEXUAL ADDICTION & COMPULSIVITY-THE JOURNAL OF TREATMENT AND PREVENTION, 2009, 16 (04): : 253 - 266
  • [23] From stress to psychosis: whom, how, when and why?
    Mondelli, V.
    [J]. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2014, 23 (03) : 215 - 218
  • [24] University teachers and technology mentoring - why, how and for whom?
    Lepp, Liina
    Remmik, Marvi
    Pedaste, Margus
    [J]. 2017 IEEE 17TH INTERNATIONAL CONFERENCE ON ADVANCED LEARNING TECHNOLOGIES (ICALT), 2017, : 379 - 383
  • [25] Transcutaneous PCO2: why, how and for whom?
    Gancel, P. -E.
    Masson, R.
    Du Cheyron, D.
    Roupie, E.
    Lofaso, F.
    Terzi, N.
    [J]. REANIMATION, 2012, 21 (02): : 221 - 230
  • [26] Tackling melanoma by adjuvant therapy: why, whom and how?
    Schilling, B.
    Wiesner, T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 1 - 2
  • [27] EARLY INTERVENTION - WHY, FOR WHOM, HOW, AND AT WHAT COST
    RAMEY, CT
    BRYANT, DM
    SUAREZ, TM
    [J]. CLINICS IN PERINATOLOGY, 1990, 17 (01) : 47 - 55
  • [28] Monitoring medical research conduct: why, how and by whom?
    Colin, T
    [J]. INTERNAL MEDICINE JOURNAL, 2006, 36 (02) : 69 - 71
  • [29] TOWARD A KNOWLEDGE-BASE - WHY, HOW, FOR WHOM
    WANG, MC
    HAERTEL, GD
    WALBERG, HJ
    [J]. REVIEW OF EDUCATIONAL RESEARCH, 1993, 63 (03) : 365 - 376
  • [30] Continuous renal replacement therapies: Whom, how, and why
    Kaplan, A.A.
    [J]. ASAIO Journal, 1994, 40 (04) : 940 - 942